Quipt Home Medical (NASDAQ:QIPT - Get Free Report) will likely be announcing its Q2 2025 earnings results after the market closes on Monday, May 12th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $88.29 million for the quarter.
Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter. Quipt Home Medical had a negative return on equity of 6.70% and a negative net margin of 2.90%. On average, analysts expect Quipt Home Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Quipt Home Medical Price Performance
NASDAQ:QIPT traded up $0.03 during midday trading on Friday, hitting $2.17. 66,615 shares of the stock were exchanged, compared to its average volume of 192,797. The business has a 50-day moving average price of $2.21 and a two-hundred day moving average price of $2.58. The company has a current ratio of 1.22, a quick ratio of 0.87 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $93.51 million, a price-to-earnings ratio of -12.76 and a beta of 0.65. Quipt Home Medical has a one year low of $1.86 and a one year high of $4.17.
Quipt Home Medical Company Profile
(
Get Free Report)
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Featured Articles
Before you consider Quipt Home Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.
While Quipt Home Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
